ImStem Biotechnology Overview

  • Founded
  • 2012
Founded
  • Status
  • Private
  • Employees
  • 8
Employees
  • Latest Deal Type
  • Debt
  • Investors
  • 3

ImStem Biotechnology General Information

Description

Operator of a biotechnology company intended to develop cell therapeutics product. The company develops cell therapeutic product derived from human pluripotent stem cells for tissue repair, treatment of neural, heart, vascular, blood system diseases and autoimmune diseases, enabling doctors to get therapeutic products to treat various autoimmune diseases.

Contact Information

Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Primary Office
  • 400 Farmington Avenue, R1808
  • Call Box 111
  • Farmington, CT 06032
  • United States
+1 (860) 000-0000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

ImStem Biotechnology Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Debt - General 07-Nov-2013 00000 Completed Generating Revenue
2. Seed Round 10-Oct-2013 00000 00000 Completed Generating Revenue
1. Grant 10-Jun-2013 $1.13M Completed Generating Revenue
To view ImStem Biotechnology’s complete valuation and funding history, request access »

ImStem Biotechnology Executive Team (4)

Name Title Board Seat Contact Info
Michael Men MD Co-Founder, Chief Executive Officer, President & Board Member
Xiaofang Wang Ph.D Co-Founder, Chief Technology Officer, Vice President and Board Member
Richard Kim MD Chief Medical Officer
To view ImStem Biotechnology’s complete executive team members history, request access »

ImStem Biotechnology Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

ImStem Biotechnology Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
CaroGen VC-Backed Company Minority 000 0000 000000 0
Connecticut Innovations Venture Capital Minority 000 0000 000000 0
Connecticut Stem Cell Research Program Other 000 0000 000000 0
To view ImStem Biotechnology’s complete investors history, request access »